FDA Inspection 1109655 — CA BOTANA International, Inc.

CA BOTANA International, Inc. — FEI 2023910

The FDA completed an inspection of CA BOTANA International, Inc. on November 12, 2019 in San Diego, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 7 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 12, 2019
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
San Diego, CA (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
117721 CFR 211.63Equipment Design, Size and Location
189121 CFR 211.165(f)Failing drug products not rejected
197521 CFR 211.182Written records kept in individual logs
356921 CFR 211.89Quarantine of Rejected Components et. al.
360321 CFR 211.160(b)Scientifically sound laboratory controls
433821 CFR 211.150(b)Recall facilitation